Akero Therapeutics
AKRO
AKRO
181 hedge funds and large institutions have $2.9B invested in Akero Therapeutics in 2023 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 79 increasing their positions, 39 reducing their positions, and 12 closing their positions.
Holders
181
Holders Change
+24
Holders Change %
+15.29%
% of All Funds
2.89%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.11%
New
38
Increased
79
Reduced
39
Closed
12
Calls
$140M
Puts
$151M
Net Calls
-$11.2M
Net Calls Change
+$8.22M
Top Buyers
| 1 |
1
AllianceBernstein
Nashville,
Tennessee
|
$64.8M |
| 2 |
2
BlackRock
New York
|
$201M |
| 3 |
ACA
3
Avoro Capital Advisors
New York
|
$28.1M |
| 4 |
4
T. Rowe Price Associates
Baltimore,
Maryland
|
$193M |
| 5 |
5
Lord, Abbett & Co
Jersey City,
New Jersey
|
$39.4M |
